Evidence map›Paper›PMID 36178974›Full record

ArticlePLoS pathogens2022

Gene expression of axenically-isolated clinical Entamoeba histolytica strains and its impact on disease severity of amebiasis.

Yasuaki Yanagawa, Shinji Izumiyama, Yumiko Saito-Nakano, Kumiko Nakada-Tsukui, Seiki Kobayashi, Naoko Yoshida, Yoshimi Kikuchi, Hiroyuki Gatanaga, Shinichi Oka, Tomoyoshi Nozaki and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Exploring virulence and stress response inMicrobiology spectrum · 2025
    Article
  4. Review
  5. Article
  6. Diversity and Plasticity of Virulent Characteristics ofTropical medicine and infectious disease · 2023
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Yasuaki YanagawaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinji IzumiyamaDepartment of Parasitology, National Institutes of Infectious Diseases, Tokyo, Japan.
Yumiko Saito-NakanoDepartment of Parasitology, National Institutes of Infectious Diseases, Tokyo, Japan.
Kumiko Nakada-TsukuiDepartment of Parasitology, National Institutes of Infectious Diseases, Tokyo, Japan.
Seiki KobayashiDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Naoko YoshidaDepartment of Tropical Medicine and Parasitology, Juntendo University School of Medicine, Tokyo, Japan.
Yoshimi KikuchiAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroyuki GatanagaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinichi OkaAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Tomoyoshi NozakiDepartment of Biochemical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Koji WatanabeAIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0002-3190-8439
National Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JPJuntendo University · JPKeio University · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severity of Entamoeba histolytica infection is determined by host immunology, pathogen virulence, and the intestinal environment. Conventional research for assessing pathogen virulence has been mainly performed using laboratory strains, such as a virulent HM-1: IMSS (HM-1) and an avirulent Rahman, under various artificial environmental conditions because of the difficulties of axenic isolation of the clinical strains. However, it is still unclear whether scientific knowledge based on laboratory strains are universally applicable to the true pathogenesis. Hereby, we performed transcriptomic analysis of clinical strains from patients with different degrees of disease severity, as well as HM-1 under different conditions. Even after several months of axenization, Clinical strains show the distinct profile in gene expression during in vitro passage, moreover, difference between any 2 of these strains was much greater than the changes on the liver challenge. Interestingly, 26 DEGs, which were closely related to the biological functions, were oppositely up- or down regulated between virulent Ax 19 (liver abscess) and avirulent Ax 11 (asymptomatic carrier). Additionally, RNAseq using laboratory strain (HM1) showed more than half of genes were differently expressed between continuously in vitro passaged HM1 (in vitro HM1) and periodically liver passaged HM1 (virulent HM1), which was much greater than the changes on the liver passage of virulent HM1. Also, transcriptomic analysis of a laboratory strain revealed that continuous environmental stress enhances its virulence via a shift in its gene expression profile. Changes in gene expression patterns on liver abscess formation were not consistent between clinical and laboratory strains.

Indexed as

AmebiasisDysentery, AmebicEntamoeba histolyticaLiver AbscessGene ExpressionHumansSeverity of Illness Index

Identifiers

PMID36178974
PMCPMC9555656
OpenAlexW4298088805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.